Harvard Teaching Hospital Reviewing J&J Ties to Psychiatry Unit
Email | Print | A A A
By Rob Waters and Julie Ziegler
Nov. 25 (Bloomberg) -- Massachusetts General Hospital will investigate conflicts of interest at a child psychiatry research center it established with funding from Johnson & Johnson, maker of the antipsychotic drug Risperdal.
The hospital, in a statement yesterday, said its grant specified the purpose of the center was scientific and educational, not to promote J&J’s products. Yet the center’s 2002 annual report said it would undertake studies that “will move forward the commercial goals of J&J,” according to documents released in connection with a lawsuit against the company.
The Johnson & Johnson Center for the Study of Pediatric Psychopathology was run by Joseph Biederman, a Harvard University child psychiatrist whose research helped fuel an explosion in the number of children diagnosed with bipolar disorder and treated with antipsychotics. His ties to J&J and other drugmakers were criticized in June by Senator Charles Grassley, an Iowa Republican, who said Biederman failed to disclose most of the .6 million he received from the industry from 2000 to 2007.
Read the rest:
http://www.bloomberg.com/apps/news?pid=20601087&sid=atN6Se0NVbp0&refer=homeLike I said before... I got no use for most of these pediatric psychopaths.
DISGUSTING
Copyright ArthritisInsight.com